Session

Clinical aspects of NAFLD

Clinical aspects of NAFLD - Panel discussion
Clinical aspects of NAFLD - Panel discussion

GUT-LIVER-AXIS: THE EFFECTS OF HEPATIC BARRIER (LIVER SINUSOIDAL ENDOTHELIAL CELL) AND NEUTROPHIL ON GUT-DERIVED LIVER INJURY
GUT-LIVER-AXIS: THE EFFECTS OF HEPATIC BARRIER (LIVER SINUSOIDAL ENDOTHELIAL CELL) AND NEUTROPHIL ON GUT-DERIVED LIVER INJURY

Clinical aspects of NAFLD

GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY: PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG ITALIAN PRIMARY CARE PATIENTS WITH NAFLD
GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY: PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG ITALIAN PRIMARY CARE PATIENTS WITH NAFLD

Clinical aspects of NAFLD

CONGLOMERATED ASSOCIATION OF LIGHT DRINKING TYPE AND DURATION ON THE DEVELOPMENT OF NON- ALCOHOLIC FATTY LIVER DISEASE: A NATIONWIDE POPULATION-BASED LONG TERM FOLLOW UP STUDY
CONGLOMERATED ASSOCIATION OF LIGHT DRINKING TYPE AND DURATION ON THE DEVELOPMENT OF NON- ALCOHOLIC FATTY LIVER DISEASE: A NATIONWIDE POPULATION-BASED LONG TERM FOLLOW UP STUDY

Clinical aspects of NAFLD

STEATDIAB A SCORE FOR IDENTIFYING TYPE 2 DIABETES MELLITUS PATIENTS AT RISK FOR DEVELOPING MODERATE STEATOSIS
STEATDIAB A SCORE FOR IDENTIFYING TYPE 2 DIABETES MELLITUS PATIENTS AT RISK FOR DEVELOPING MODERATE STEATOSIS

Clinical aspects of NAFLD

INCREASED ABUNDANCE OF LACTOCOCCUS LACTIS AS A FECAL BIOMARKER PREDICTING DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AFTER FECAL MICROBIOTA TRANSPLANTATION IN HUMAN MICROBIOTA-ASSOCIATED RODENTS
INCREASED ABUNDANCE OF LACTOCOCCUS LACTIS AS A FECAL BIOMARKER PREDICTING DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AFTER FECAL MICROBIOTA TRANSPLANTATION IN HUMAN MICROBIOTA-ASSOCIATED RODENTS

Clinical aspects of NAFLD

Item 1 - 6 / 6
1